Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 450
- 主要终点
- Oncoprint of somatic mutations
研究概览
简要总结
Lung adenocarcinomas (LUADs) from Asian ancestry are reported to have different genomic architectures compared with LUADs from Caucasian ancestry. However, due to lack of available cases, few studies controlled the clinical attributes during the comparisons of the genomic alterations. In this study, the investigators will identify Asian LUADs patients who had broad-panel next-generation sequencing (NGS) performed on their primary tumor between January 2018 and December 2019 at the department of thoracic surgery of Peking University People's Hospital. Then, Caucasian LUADs patients who had targeted NGS (Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets [MSK-IMPACT]) will be identified in the GENIE database, which consists of 6673 primary lung adenocarcinoma samples with clinical annotations. Finally, genomic alterations regarding somatic mutations, copy number variations, fusions, mutational signatures, oncogenic pathways, and therapeutic actionability will be comprehensively compared between these two cohorts after adjusting age, sex, smoking status, and pathologic stage using propensity score matching. This study will elucidate important ancestry differences between Asian and Caucasian lung adenocarcinoma patients.
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 85 Years(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Primary lung adenocarcinoma
- •Broad-panel next-generation sequencing
排除标准
- •Inadequate clinicopathological information
- •Low-quality next-generation sequencing
结局指标
主要结局
Oncoprint of somatic mutations
时间窗: July 2021
Association between genomic features and race
Copy number variations (CNVs)
时间窗: July 2021
CNVs analysis by race
Mutational signatures
时间窗: August 2021
Analysis of mutational signatures by race
Oncogenic pathways
时间窗: September 2021
Analysis of oncogenic pathways by race
Therapeutic actionability
时间窗: October 2021
Analysis of actionable alterations by race
次要结局
未报告次要终点
研究者
Jun Wang
Professor
Peking University People's Hospital
